What is IBEX's health score?

IBEX Ltd (IBEX) has a TradeApes health score of 68 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is IBEX's estimated fair value?

Based on our 5-year discounted cash flow model, IBEX Ltd's estimated fair value is $40.35 per share, representing a 25.3% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is IBEX undervalued or overvalued?

Our model currently rates IBEX as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for IBEX... Refresh in a moment for the full analysis.

IBEX Ltd (IBEX)

Technology Undervalued low healthy

$32.21

Updated: 2026-06-02

TradeApes Score

Financial Strength

75 Strong

Operating Trend

60 Healthy

Relative Value

65 Healthy

Capital Allocation

65 Healthy

Risk

80 Strong

Est. Fair Value $40.35

DCF Upside +25.3%

Sector Rank #463 of 7748

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.